Mylan N.V., formerly Mylan Inc., is a global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan operates in two segments: Generics and Specialty. The Company’s generic pharmaceutical business is conducted primarily in the United States and Canada (collectively, North America); Europe, the Middle East, and Africa (collectively, EMEA); and India, Australia, Japan and New Zealand (collectively, Asia Pacific). Its specialty pharmaceutical business is conducted by Mylan Specialty L.P. (Mylan Specialty). The Company’s API business is conducted through Mylan Laboratories Limited (Mylan India), which is included within the Asia Pacific region in its Generics Segment. Mylan provides products to customers in approximately 140 countries and territories.
Hatfield, GB
35,000 (est)
Mylan is headquartered in Hatfield, GB

Mylan Locations

Hatfield, GB

Mylan Metrics

Mylan Summary

Market capitalization

$19.8 B

Closing share price

Mylan's current market capitalization is $19.8 B.

Mylan Market Value History

Mylan Online Presence

Mylan News

Mylan Company Life

You may also be interested in